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One ROCK is not like another
 
he mammalian rho kinases, ROCKI and ROCKII, control distinct cytoskeletal
functions from distinct locations, report Yoneda et al. on page 443. ROCKI
is required for formation of actin stress fibers and cell adhesion, whereas
ROCKII is needed for phagocytosis.
The ROCK proteins are major effectors of the Rho signaling pathway, controlling
cell adhesion, motility, and other actin-based functions. In kinase overexpression assays,
ROCKI and ROCKII appear redundant, but several experiments, including mouse
knock-outs, hinted that the proteins have unique duties despite their structural similarity.
While studying a signaling pathway that links integrins and cell surface
proteoglycans to adhesion, Yoneda et al. saw that ROCKI but not ROCKII activity
increased during adhesion. To learn how the proteins differ functionally, the team
knocked down each ROCK gene independently using siRNA sequences that left
the other gene unchanged. Cells lacking ROCKI formed few stress fibers or focal
adhesions. ROCKII-depleted cells produced oversized stress fibers and adhesions, and
showed problems with phagocytic uptake of fibronectin-coated beads.
The PH domain is the most divergent region of the two ROCKs, and GFP-PH
from each protein localized to distinct subcellular locations. The ROCKI PH domain
was evenly distributed at membranes, whereas ROCKII PH concentrated in ruffles at
the cell surface. Subsequent analysis showed that only ROCKII PH binds to PIP
 
3
 
 lipids
and may, therefore, be regulated by PI3-kinase.
Although the ROCK proteins phosphorylate similar targets in vitro, Yoneda et al.
think that subcellular targeting restricts the pair’s functions. This is consistent with over-
expression of either protein masking their differences. If the team is right, then what holds
for real estate holds for the ROCKs: it’s all about location, location, location. 
T
Cells low in ROCKI (center) lack stress fibers.
 
NAD to the rescue
 
AD helps counteract energy leakage from severed axons, report
Wang et al. on page 349.
Recently, Araki et al. (
 
Science
 
. 305:1010–1013) showed that
NAD protects axons from degeneration after injury, apparently by acti-
vating SIRT1, a nuclear deacetylase involved in aging. Now, Wang et al.
show that NAD prevents degeneration independent of SIRT1 and works
locally to protect membrane integrity.
Axons degenerate when they are cut from their cell body. However,
neurons from mice are protected from degeneration when they over-
express either Nmnat1, which synthesizes NAD, or the Wld
 
s
 
 fusion pro-
tein that contains Nmnat1.
Wang et al. found that overexpression of Wld
 
s
 
 or Nmnat1 prevented
a decrease of NAD, normally seen in axons after severing, and delayed
degeneration. Moreover, addition of NAD to culture media delayed axonal
N
Severed axons degenerate (top; left to right) but can be 
rescued by Nmat expression or NAD (bottom).
 
degeneration, even when it was added to an axonal segment already isolated from its soma. This suggests
that NAD acts locally rather than via transcription. Because NAD is essential for ATP synthesis, and a drop in
ATP parallels the drop in NAD in severed axons, the team asked if exogenous pyruvate could delay degeneration.
The energy-rich chemical did protect axons, indicating that NAD may be required to sustain ATP levels necessary
to maintain the integrity of the cell boundary.
So what is the difference between this work and the earlier study? It could be that Wang et al. used higher
concentrations of NAD and thereby bypassed a need for transcriptional activation of SIRT1. No difference after
NAD addition in neurons from wild-type and SIRT1-deficient mice makes that less likely. Instead, Wang et al.
point to the contrast between isolated axons in their study and surrounding glial cells in the Araki et al. study. 
The real test of NAD’s protective abilities will come when Wang et al. start to look at neurons in the brains of an-
imals. Such cells are postmitotic and can’t synthesize NAD from tryptophan. If they start to lose NAD for some reason,
such as axonal injury, they may become more susceptible to degeneration—and adding it back may be protective. 
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